FDA.reportPublic FDA data

Protein 14-3-3 IVD, reagent

Definition
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of protein 14-3-3 in a clinical specimen.
GUDID devices
19
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00628425360044AugurexAugurex Life Sciences Corp1.02026-04-20
00628425360075AuguerxAugurex Life Sciences Corp1.02026-04-20
00628425360082AugurexAugurex Life Sciences Corp1.02026-04-20
00628425360099AugurexAugurex Life Sciences Corp1.02026-04-20
00628425360105AugurexAugurex Life Sciences Corp1.02026-04-20
00628425360112AugurexAugurex Life Sciences Corp1.02026-04-20
00628425360129AugurexAugurex Life Sciences Corp1.02026-04-20
06284510990387Augurex Life SciencesCedarlane Corporation90-00052022-12-08
06284510990400Augurex Life SciencesCedarlane Corporation90-00202022-12-08
06284510990417Augurex Life SciencesCedarlane Corporation90-00092022-12-08
06284510990431Augurex Life SciencesCedarlane Corporation90-00212022-12-08
06284510990448Augurex Life SciencesCedarlane Corporation90-00312022-12-08
06284510990455Augurex Life SciencesCedarlane Corporation90-00132022-12-08
06284510990462Augurex Life SciencesCedarlane Corporation90-00152022-12-08
06284510990479Augurex Life SciencesCedarlane Corporation90-00162022-12-08
00628425360006AugurexAugurex Life Sciences Corp1.02024-10-23
00628425360013AugurexAugurex Life Sciences Corp1.02024-10-23
00628425360020AugurexAugurex Life Sciences Corp1.02024-10-23
00628425360037AugurexAugurex Life Sciences Corp1.02024-10-23